Cargando…

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)

BACKGROUND: Identification of somatic mutations in key oncogenes in melanoma is important to lead the effective and efficient use of personalized anticancer treatment. Conventional methods focus on few genes per run and, therefore, are unable to screen for multiple genes simultaneously. The use of N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanni, Irene, Casula, Milena, Pastorino, Lorenza, Manca, Antonella, Dalmasso, Bruna, Andreotti, Virginia, Pisano, Marina, Colombino, Maria, Pfeffer, Ulrich, Tanda, Enrica Teresa, Rozzo, Carla, Paliogiannis, Panagiotis, Cossu, Antonio, Ghiorzo, Paola, Palmieri, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737361/ https://www.ncbi.nlm.nih.gov/pubmed/33317587 http://dx.doi.org/10.1186/s13000-020-01052-5

Ejemplares similares

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020)

Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy?
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
por: Bruno, W., et al.
Publicado: (2022)

Vitamin D status and risk for malignant cutaneous melanoma: recent advances
por: Ombra, Maria N., et al.
Publicado: (2017)

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022)

Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients
por: Colombino, Maria, et al.
Publicado: (2020)

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
por: Vanni, Irene, et al.
Publicado: (2020)

The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI)
por: Elefanti, Lisa, et al.
Publicado: (2021)

Current State of Target Treatment in BRAF Mutated Melanoma
por: Tanda, Enrica Teresa, et al.
Publicado: (2020)

Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients
por: Ciccarese, Giulia, et al.
Publicado: (2020)

Primary Melanoma of the Lung: A Systematic Review
por: Paliogiannis, Panagiotis, et al.
Publicado: (2020)

Genetic alterations in main candidate genes during melanoma progression
por: Sini, Maria Cristina, et al.
Publicado: (2018)

Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
por: Manca, Antonella, et al.
Publicado: (2019)

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
por: Vanni, Irene, et al.
Publicado: (2023)

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
por: Guida, Michele, et al.
Publicado: (2021)

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2017)

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2018)

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry
por: Bruno, William, et al.
Publicado: (2016)

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective
por: Ombra, Maria Neve, et al.
Publicado: (2019)

Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
por: Pastorino, Lorenza, et al.
Publicado: (2020)

BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas
por: Colombino, Maria, et al.
Publicado: (2019)

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
por: Casula, Milena, et al.
Publicado: (2019)

Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases
por: Palmieri, G, et al.
Publicado: (2000)

Current Trends in Mucosal Melanomas: An Overview
por: Santeufemia, Davide Adriano, et al.
Publicado: (2023)

KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors
por: Palomba, Grazia, et al.
Publicado: (2020)

Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma
por: Casula, Milena, et al.
Publicado: (2023)

EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
por: Colombino, Maria, et al.
Publicado: (2019)

Primary Dermal Melanoma in a Patient with a History of Multiple Malignancies: A Case Report with Molecular Characterization
por: Sini, Germana, et al.
Publicado: (2013)

Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells
por: Pisano, Marina, et al.
Publicado: (2010)

Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)
por: Mandalà, Mario, et al.
Publicado: (2020)

Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study
por: Paliogiannis, Panagiotis, et al.
Publicado: (2022)

Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
por: Palmieri, Giuseppe, et al.
Publicado: (2015)

Anticancer Activity of Two Novel Hydroxylated Biphenyl Compounds toward Malignant Melanoma Cells
por: Pisano, Marina, et al.
Publicado: (2021)

Discrepant alterations in main candidate genes among multiple primary melanomas
por: Colombino, Maria, et al.
Publicado: (2014)

Issues affecting molecular staging in the management of patients with melanoma
por: Palmieri, G, et al.
Publicado: (2007)

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
por: Spagnolo, Francesco, et al.
Publicado: (2015)

Perivascular Epithelioid Cell Tumors (PEComas) of the Orbit
por: Paliogiannis, Panagiotis, et al.
Publicado: (2017)

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
por: Palmieri, Giuseppe, et al.
Publicado: (2018)

Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study
por: Marconcini, Riccardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jjvphe4piguc512k0lr92hkj32